Isabel Meininger

574 citations
10 papers · 447 indexed · h-index 10
Topics
NF-κB Signaling Pathways (4 papers)interferon and immune responses (3 papers)IL-33, ST2, and ILC Pathways (3 papers)
Partner nations
GermanySwedenJapan

In The Last Decade

Isabel Meininger

10 papers receiving 441 citations

Peers

Isabel Meininger
Comparison fields: 5 of 59
  • Immunology 284
  • Molecular Biology 179
  • Surgery 95
  • Cancer Research 92
  • Oncology 66
Replace Prathyusha Gudapati with:
Prathyusha Gudapati United States
Dilip Kumar Singapore
X. Niu China
Katalin Olasz Hungary
A Shikotra United Kingdom
Danielle A. Chisolm United States
Marina Castellano Australia
Madhura Modak Austria
Katharina M. Jeltsch Germany
L A Turka United States
Isabel Meininger relative to Prathyusha Gudapati United States Prathyusha Gudapati's profile →
Citations per field
00.5×4.7×
Prathyusha Gudapati · 1×
Citations per year

Countries citing papers authored by Isabel Meininger

Since Specialization
Citations

This map shows the geographic impact of Isabel Meininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Meininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Meininger more than expected).

Fields of papers citing papers by Isabel Meininger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Meininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Meininger. The network helps show where Isabel Meininger may publish in the future.

Co-authorship network of co-authors of Isabel Meininger

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Meininger. A scholar is included among the top collaborators of Isabel Meininger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Meininger. Isabel Meininger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 28
2 123
3 22
4 10
5 57
6 49
7 81
8 54
9 12
10 11

About Isabel Meininger

Isabel Meininger is a scholar working on Immunology, Cancer Research and Dermatology, having authored 10 papers that have together received 447 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (4 papers), interferon and immune responses (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). The work is most often cited by research in Immunology (284 citations), Cancer Research (92 citations) and Immunology and Allergy (19 citations). Isabel Meininger has collaborated with scholars based in Germany, Sweden and Japan. Frequent co-authors include Daniel Krappmann, Anna Carrasco, Tea Soini, Efthymia Kokkinou, Jenny Mjösberg, Anna Rao, Michael Sattler, Torben Gehring, Thomas Brocker and Carina Graß. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026